All News Mesoblast Limited Nasdaq

Equities

MESO

US5907174016

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-21 EDT			5-day change	1st Jan Change
7.91 ^USD	+8.21%		+9.86%	+259.55%

04-01	ADRs End Higher; Connect Biopharma Climbs 26%	DJ
03-28	ADRs End Lower; NuCana Slides 15%	DJ

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2024	04-29	AQ
ADRs End Higher; Connect Biopharma Climbs 26%	04-01	DJ
ADRs End Lower; NuCana Slides 15%	03-28	DJ
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK	03-28	AQ
ADRs End Lower; Quhuo Drops 53%	03-26	DJ
FDA Says Mesoblast Trial Data Sufficient to Support BLA Submission	03-26	MT
Sector Update: Health Care Stocks Advance Late Afternoon	03-26	MT
Top Midday Gainers	03-26	MT
Sector Update: Health Care Stocks Steady Premarket Tuesday	03-26	MT
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	03-26	MT
Top Premarket Gainers	03-26	MT
Mesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Application	03-26	DJ
Mesoblast to Resubmit Application for Potential Pediatric Treatment of Graft Versus Host Disease; Shares Gain Pre-Bell	03-26	MT
United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)	03-25	AQ
United States Food & Drug Administration Notifies Mesoblast Limited of Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease	03-25	CI
Mesoblast Limited(ASX:MSB) added to S&P/ASX Emerging Companies Index	03-17	CI
Mesoblast Raises AU$97 Million From Entitlement Offer, Institutional Placement	03-14	MT
Mesoblast Raises AU$97 Million for Phase Three Registration Trials	03-14	MT
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer	03-13	AQ
Sector Update: Health Care Stocks Softer Late Afternoon	03-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Mesoblast Limited Nasdaq

Equities

MESO

US5907174016

All News

Filters